Chikhaoui Asma, Elouej Sahar, Nabouli Imen, Jones Meriem, Lagarde Arnaud, Ben Rekaya Meriem, Messaoud Olfa, Hamdi Yosr, Zghal Mohamed, Delague Valerie, Levy Nicolas, De Sandre-Giovannoli Annachiara, Abdelhak Sonia, Yacoub-Youssef Houda
Laboratoire de Génomique Biomédicale et Oncogénétique, Institut Pasteur de Tunis, Université de Tunis El Manar, Tunis, Tunisia.
Aix Marseille Univ, Inserm, MMG, U 1251, Marseille, France.
Front Genet. 2019 Feb 14;10:111. doi: 10.3389/fgene.2019.00111. eCollection 2019.
Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder due to a defect in the nucleotide excision repair (NER) DNA repair pathway, characterized by severe sunburn development of freckles, premature skin aging, and susceptibility to develop cancers at an average age of eight. XP is an example of accelerated photo-aging. It is a genetically and clinically heterogeneous disease. Eight complementation groups have been described worldwide. In Tunisia, five groups have been already identified. In this work, we investigated the genetic etiology in a family with an atypically mild XP phenotype. Two Tunisian siblings born from first-degree consanguineous parents underwent clinical examination in the dermatology department of the Charles Nicolle Hospital on the basis of acute sunburn reaction and mild neurological disorders. Blood samples were collected from two affected siblings after written informed consent. As all mutations reported in Tunisia have been excluded using Sanger sequencing, we carried out mutational analysis through a targeted panel of gene sequencing using the Agilent HaloPlex target enrichment system. Our clinical study shows, in both patients, the presence of achromic macula in sun exposed area with dermatological feature suggestive of Xeroderma pigmentosum disease. No developmental and neurological disorders were observed except mild intellectual disability. Genetic investigation shows that both patients were carriers of an homozygous T to C transition at the nucleotide position c.2333, causing the leucine to proline amino acid change at the position 778 (p.Leu778Pro) of the gene, and resulting in an XP-G phenotype. The same variation was previously reported at the heterozygous state in a patient cell line in Europe, for which no clinical data were available and was suggested to confer an XP/CS phenotype based on functional tests. This study contributes to further characterization of the mutation spectrum of XP in consanguineous Tunisian families and is potentially helpful for early diagnosis. It also indicates that the genotype-phenotype correlation is not always coherent for patients with mild clinical features. These data therefore suggest that targeted NGS is a highly informative diagnostic strategy, which can be used for XP molecular etiology determination.
着色性干皮病(XP)是一种罕见的常染色体隐性疾病,由于核苷酸切除修复(NER)DNA修复途径存在缺陷,其特征为严重晒伤、雀斑形成、皮肤过早老化,且平均在8岁时易患癌症。XP是加速光老化的一个例子。它是一种遗传和临床异质性疾病。全球已描述了8个互补组。在突尼斯,已鉴定出5个组。在这项研究中,我们调查了一个具有非典型轻度XP表型的家庭的遗传病因。两名来自一级近亲父母的突尼斯兄弟姐妹因急性晒伤反应和轻度神经障碍,在查尔斯·尼科尔医院皮肤科接受了临床检查。在获得书面知情同意后,从两名受影响的兄弟姐妹采集了血样。由于使用桑格测序法已排除突尼斯报道的所有突变,我们通过使用安捷伦HaloPlex目标富集系统的靶向基因测序面板进行了突变分析。我们的临床研究表明,在两名患者中,暴露于阳光下的区域存在无色斑,其皮肤特征提示着色性干皮病。除轻度智力残疾外,未观察到发育和神经障碍。基因研究表明,两名患者在核苷酸位置c.2333处均为纯合T到C转换的携带者,导致该基因第778位(p.Leu778Pro)的亮氨酸变为脯氨酸氨基酸改变,从而产生XP - G表型。此前在欧洲的一个患者细胞系中曾报道过相同变异的杂合状态,但无临床数据,且根据功能测试提示其具有XP/CS表型。本研究有助于进一步表征近亲突尼斯家庭中XP的突变谱,对早期诊断可能有帮助。它还表明,对于临床特征较轻的患者,基因型 - 表型相关性并不总是一致的。因此,这些数据表明靶向二代测序是一种信息丰富的诊断策略,可用于XP分子病因的确定。